Wintrust Investments LLC Takes Position in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Wintrust Investments LLC acquired a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 8,285 shares of the company’s stock, valued at approximately $653,000. Wintrust Investments LLC owned 0.18% of VanEck Pharmaceutical ETF as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Bank of America Corp DE boosted its holdings in shares of VanEck Pharmaceutical ETF by 161.4% during the 1st quarter. Bank of America Corp DE now owns 778,144 shares of the company’s stock worth $60,407,000 after buying an additional 480,478 shares in the last quarter. BNP Paribas Arbitrage SNC boosted its stake in VanEck Pharmaceutical ETF by 298.8% during the second quarter. BNP Paribas Arbitrage SNC now owns 400,800 shares of the company’s stock worth $31,571,000 after acquiring an additional 300,300 shares in the last quarter. Avalon Trust Co acquired a new stake in VanEck Pharmaceutical ETF in the first quarter worth $22,231,000. Goldman Sachs Group Inc. increased its stake in VanEck Pharmaceutical ETF by 144.5% in the second quarter. Goldman Sachs Group Inc. now owns 359,687 shares of the company’s stock valued at $27,638,000 after purchasing an additional 212,560 shares in the last quarter. Finally, HRT Financial LP raised its holdings in shares of VanEck Pharmaceutical ETF by 1,225.5% during the first quarter. HRT Financial LP now owns 67,098 shares of the company’s stock valued at $5,208,000 after purchasing an additional 62,036 shares during the period.

VanEck Pharmaceutical ETF Price Performance

PPH stock opened at $76.82 on Friday. The company’s 50-day moving average is $78.89 and its 200-day moving average is $79.02. The stock has a market capitalization of $391.01 million, a PE ratio of 16.59 and a beta of 0.72. VanEck Pharmaceutical ETF has a 1 year low of $72.59 and a 1 year high of $83.35.

VanEck Pharmaceutical ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 6th. Shareholders of record on Tuesday, October 3rd were issued a $0.3398 dividend. The ex-dividend date was Monday, October 2nd. This represents a $1.36 annualized dividend and a yield of 1.77%.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.